(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[7,6-h]isochromen-7-one;53-39-4;D00462;Oxandrin (TN);Oxandrolone (JAN/USP/INN);2-Oxa-5alpha-androstan-3-one, 17beta-hydroxy-17-methyl-;(4aS,4bS,6aS,7S,9aS,9bR,11aS)-7-hydroxy-4a,6a,7-trimethyltetradecahydroindeno[4,5-h]isochromen-2(1H)-one;C07346;Oxandrolone;17-beta-hydroxy-17-methyl-2-oxa-androstan-3-one (9CI);17beta-Hydroxy-17-methyl-2-oxa-5alpha-androstan-3-one;2-Oxa-5-alpha-androstan-3-one, 17-beta-hydroxy-17-methyl-;(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[7,6-h]isochromen-7-one;2-Oxa-5alpha-androstan-3-one, 17beta-hydroxy-17-methyl- (8CI);2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5-alpha,17-beta)- (9CI);2-Oxaandrostan-3-one, 17-hydroxy-17-methyl-, (5alpha,17beta)-;8075 C.B.;8075 CB;Dodecahydro-3-hydroxy-6-(hydroxy-methyl)-3,3a,6-trimethyl-1H-benz(e)indene-7-acetic acid delta-lactone;EINECS 200-172-9;HSDB 3373;NSC 67068;Ossandrolone [DCIT];Oxandrin;Oxandrolona [INN-Spanish];Oxandrolone [USAN:BAN:INN:JAN];Oxandrolonum [INN-Latin]
(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[7,6-h]isochromen-7-one